Search research articles
Contact Us
Filters
Showing results (371-380 of 477) with videos related to
Page
of 48
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
February 5, 2011
Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group
Sohei Yamamoto, Atsuko Kasajima, Masashi Takano, et al.
International Journal of Clinical Oncology
|
August 19, 2007
Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis
Masashi Takano, Toru Sugiyama, Nobuo Yaegashi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 17, 2009
The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study
Masashi Takano, Toru Sugiyama, Nobuo Yaegashi, et al.
American Journal of Cancer Research
|
December 2, 2016
Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction
Nobuyuki Watanabe, Shuhei Komatsu, Daisuke Ichikawa, et al.
In Vivo (Athens, Greece)
|
April 27, 2018
A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas
Hiroaki Soyama, Morikazu Miyamoto, Masashi Takano, et al.
Oncology
|
March 6, 2017
Small Foci of Serous Component as a Predictor of Recurrence and Prognosis for Stage IA Endometrial Carcinomas
Morikazu Miyamoto, Masashi Takano, Hitoshi Tsuda, et al.
Gynecologic Oncology
|
January 28, 2020
Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma
Kazuhiro Takehara, Natsumi Yamashita, Reiko Watanabe, et al.
BMC Cancer
|
December 24, 2008
Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer
Shigeto Ueda, Nobuo Kondoh, Hitoshi Tsuda, et al.
Breast Cancer (Tokyo, Japan)
|
May 2, 2022
Correction to: Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama, et al.
Cancer Medicine
|
February 9, 2022
Clinical significance of CD8-positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high-grade serous carcinoma
Hideki Iwahashi, Morikazu Miyamoto, Tsubasa Ito, et al.
Page
of 48
Search research articles
Search
Showing results (371-380 of 477) with videos related to
Sort By:
Page
of 48
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
February 5, 2011
Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group
Sohei Yamamoto, Atsuko Kasajima, Masashi Takano, et al.
International Journal of Clinical Oncology
|
August 19, 2007
Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis
Masashi Takano, Toru Sugiyama, Nobuo Yaegashi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 17, 2009
The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study
Masashi Takano, Toru Sugiyama, Nobuo Yaegashi, et al.
American Journal of Cancer Research
|
December 2, 2016
Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction
Nobuyuki Watanabe, Shuhei Komatsu, Daisuke Ichikawa, et al.
In Vivo (Athens, Greece)
|
April 27, 2018
A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas
Hiroaki Soyama, Morikazu Miyamoto, Masashi Takano, et al.
Oncology
|
March 6, 2017
Small Foci of Serous Component as a Predictor of Recurrence and Prognosis for Stage IA Endometrial Carcinomas
Morikazu Miyamoto, Masashi Takano, Hitoshi Tsuda, et al.
Gynecologic Oncology
|
January 28, 2020
Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma
Kazuhiro Takehara, Natsumi Yamashita, Reiko Watanabe, et al.
BMC Cancer
|
December 24, 2008
Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer
Shigeto Ueda, Nobuo Kondoh, Hitoshi Tsuda, et al.
Breast Cancer (Tokyo, Japan)
|
May 2, 2022
Correction to: Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama, et al.
Cancer Medicine
|
February 9, 2022
Clinical significance of CD8-positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high-grade serous carcinoma
Hideki Iwahashi, Morikazu Miyamoto, Tsubasa Ito, et al.
Page
of 48